What long-term care looks like around the world

Around the world, wealthy countries are struggling to afford long-term care for rapidly aging populations.

Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMR

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the

October 27, 2024

Departing Stanford president retracts two widely cited papers, against lead author’s wishes

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted

August 31, 2023

Studies link gut dysbiosis to pancreatic cancer, offering pathways for early detection

The gut microbiome’s impact on pancreatic cancer highlights potential for early screening and fecal microbiota transplantation in improving treatment efficacy.

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.